The Reformulary Group Revenue and Competitors

WE'RE HIRING: - Director, Sales/Channel - Account Executive, Sales/Channel - Manager, Product For more information or to submit your CV, email: JoinOurTeam@reformulary.com Founded in 2011 by Helen Stevenson, Reformulary Group is an expert-led healthcare technology company focused on helping Canadians and companies make sense of medicine. Our proprietary drug list, the Reformulary®, is a subscription-based product offered to Canadian employers, unions, and associations. The Reformulary provides Canadians with valuable comparative drug information, reviewed, and vetted by an independent committee of doctors and pharmacists from across Canada. In 2019, we were selected a CIX TOP 20 Early Innovative Canadian technology start-up, and in 2018, Reformulary Group won the TELUS Outstanding Product Achievement Award. Reformulary Group also developed and launched Cannabis Standard, a proprietary medical cannabis formulary that includes a Discovery Tool to guide Canadians in considering whether medical cannabis is a good option for them. It includes evidence-based tools for patients to self-report the impact of medicine on their quality of life. Through our formulary business, we have amassed proprietary - and acquired - datasets that we are connecting in new, insightful and exciting ways. Reformulary Group is a privately held company headquartered in downtown Toronto.